Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Study to Determine the Maximum Tolerated Dose and Evaluate the Efficacy and Safety of CEP-18770 (Delanzomib) in Patients With Relapsed Multiple Myeloma Refractory to the Most Recent Therapy

Cephalon · 2010
ClinicalTrials.gov · Datasets · License: Public Domain · 2010
Open Source ↗
multiple-myeloma
multiple myeloma, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 1030136
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.